Dry Skin

5

Review clinical trials related to Dry Skin. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

An Open-label, Single-arm Interventional Study to Evaluate the Safety and Efficacy of a Probiotic-containing Cream in Children With Dry Skin

The DermaKIDS study is an open-label, single-arm interventional study designed to evaluate the safety and efficacy of a probiotic-containing cream in children with dry skin. Approximately 40 children aged from newborn to 7 years will be enrolled at two study sites in Portugal. Participants will apply the study cream twice daily for a period of four weeks under normal home-use conditions. The primary efficacy endpoint is the change in Overall Dry Skin Score (ODS) from baseline to the end of the study. Safety and efficacy will be assessed through investigator evaluations combined with weekly parent-reported diaries and standardized photographs.

Participants needed: 40
Trial details
Age: 0-7Biological sex: AllType: InterventionalSponsor: BioGaia ABUpdated: Jul 20, 2026Locations: 1
Eligibility criteria

Newborn - 7 years. [+3]

Topical medicated treatments on target area within 2 weeks. [+4]

Status: Not yet recruiting

Evaluation of the Effect of Combined Use of Cosmetic Products for Dry and Itchy Skin.

The goal of this study is to learn if combined use of shower oleogel and body lotion works to improve skin itching and dryness in adults. It will also learn about its safety. The main question it aims to answer is: • Does the products use improves skin hydration and itching? Researchers will compare shower oleogel and body lotion to a commercially available shower gel and the body lotion to see if the combined use is more efficient than use of body lotion alone. Participants will: * Use assigned products every day for 1 month * Visit the CRO for checkups and tests on established schedule

Participants needed: 60
Trial details
Age: 18-70Biological sex: AllType: InterventionalSponsor: Lacer S.A.Updated: Jul 10, 2026Locations: 1
Eligibility criteria

Age: 18-70 years old [+4]

cutaneous marks on the experimental areas, which could interfere with the assess... [+16]

Status: Recruiting

Evaluation of Oral Collagen Peptides on Skin Barrier Function in Women

This clinical study aims to determine whether taking two different doses of collagen-derived peptides for three months improves facial skin barrier integrity in women with dry, sensitive skin, compared with a placebo.

Participants needed: 75
Trial details
Age: 45-70Biological sex: FemaleType: InterventionalSponsor: Centre de Pharmacologie Clinique Applique a la DermatologieUpdated: May 12, 2026Locations: 1
Eligibility criteria

Participant having signed an Informed Consent Form (ICF); [+8]

Participant with a BMI ≤17 or ≥30 kg/cm²; [+16]

Status: Not yet recruiting

A Clinical Study to Assess the Safety and Effectiveness of Test Product in Healthy Adult Human Subjects With Dry or Sensitive Skin

This exploratory, prospective, open-label, single-centre, safety, efficacy and in-use tolerability study of the test product in healthy adult human subjects with dry or sensitive skin.

Participants needed: 32
Trial details
Age: 18-55Biological sex: AllType: InterventionalSponsor: SAVA Healthcare LimitedUpdated: Apr 24, 2025Locations: 1
Eligibility criteria

Age: 18 to 55 years (both inclusive) at the time of consent. [+11]

History of any dermatological condition of the skin diseases. [+12]

Status: Not yet recruiting

A Clinical Study to Assess the Safety and Effectiveness of Utixira Lotion and Utixira Tablet in Healthy Adult Human Subjects With Dry or Sensitive Skin Prone to Mild to Moderate Pruritus and Urticaria

This exploratory, prospective, open-label, single-centre, safety, efficacy and in-use tolerability study of the Utixira Lotion + Utixira Lotion as regimen in healthy adult human subjects with dry or sensitive skin and prone to mild to moderate pruritus or urticaria

Participants needed: 32
Trial details
Age: 18-55Biological sex: AllType: InterventionalSponsor: SAVA Healthcare LimitedUpdated: Apr 18, 2025
Eligibility criteria

Age: 18 to 55 years (both inclusive) at the time of consent. [+12]

History of any dermatological condition of the skin diseases. [+11]